GDERF
GALDERMA GROUP AG
Price Chart
Latest Quote
$230.32
+22.02 (+10.57%)
Current Price
| Previous Close | $208.30 |
| Open | $219.35 |
| Day High | $219.35 |
| Day Low | $219.35 |
| Volume | 1 |
Stock Information
| Quarterly Dividend / Yield | $0.45 / 0.19% |
| Shares Outstanding | 234.57M |
| Quarterly Dividend Yield | 0.19% |
| Quarterly Dividend | $0.45 |
| Total Debt | $2.75B |
| Cash Equivalents | $780.00M |
| Revenue | $5.24B |
| Net Income | $613.00M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $54.03B |
| P/E Ratio | 89.27 |
| EPS (TTM) | $2.58 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $56.00B |
| Sales | $5.24B |
| Income | $613.00M |
| Book/sh | $34.74 |
| Cash/sh | $3.33 |
| Employees | 8K |
Financial Ratios
| Quick Ratio | 0.90 |
| Current Ratio | 1.19 |
| Debt/Eq | 33.80 |
| EPS Growth TTM | 127.70% |
Returns & Margins
| ROA | 4.25% |
| ROE | 7.69% |
| Gross Margin | 68.86% |
| Operating Margin | 17.80% |
| Profit Margin | 11.70% |
Ownership
| Insider Ownership | 21.02% |
| Institutional Ownership | 44.30% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 2.11 |
| P/S | 10.31 |
| P/B | 6.63 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $210.27 |
| SMA50 | $207.09 |
| SMA200 | $193.51 |
| RSI | 54.02 |
| ATR | 14.5093 |
| Shares Float | 132.65M |
| Volatility | -0.06 |
| Rel Volume | 0.21 |
Performance History
| Week | +12.82% |
| Month | +17.94% |
| Quarter | +22.32% |
| 6 Months | +12.21% |
| YTD | +12.21% |
| Year | +60.88% |
| 10 Years | +200.89% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $230.32 | 300 |
| 2026-06-18 | $208.30 | 9,800 |
| 2026-06-17 | $225.70 | 700 |
| 2026-06-16 | $219.12 | 100 |
| 2026-06-15 | $210.60 | 100 |
| 2026-06-12 | $204.15 | 6,600 |
| 2026-06-11 | $201.75 | 100 |
| 2026-06-10 | $208.22 | 300 |
| 2026-06-09 | $202.50 | 10,000 |
| 2026-06-08 | $199.95 | 100 |
| 2026-06-05 | $194.60 | 100 |
| 2026-06-04 | $213.50 | 100 |
| 2026-06-03 | $196.05 | 100 |
| 2026-06-02 | $218.50 | 100 |
| 2026-06-01 | $218.85 | 100 |
| 2026-05-29 | $215.15 | 0 |
| 2026-05-28 | $215.15 | 100 |
| 2026-05-27 | $200.10 | 200 |
| 2026-05-26 | $210.85 | 100 |
About GALDERMA GROUP AG
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
đ° Latest News
Is Eledon Pharmaceuticals (ELDN) Outperforming Other Medical Stocks This Year?
Zacks âĸ 2026-06-16T13:40:02Z
What Makes Galderma Group AG - Unsponsored ADR (GALDY) a New Strong Buy Stock
Zacks âĸ 2026-05-05T16:00:04Z
European Market Insights 3 Stocks Estimated Below Fair Value
Simply Wall St. âĸ 2026-04-29T10:37:57Z
3 European Stocks Estimated To Be Up To 48.1% Below Intrinsic Value
Simply Wall St. âĸ 2026-04-29T05:38:03Z
Assessing Galderma Group (SWX:GALD) Valuation After Recent Share Price Resilience
Simply Wall St. âĸ 2026-03-26T18:07:06Z
Assessing Galderma Group (SWX:GALD) Valuation After Record 2025 Results And Upgraded Nemluvio Outlook
Simply Wall St. âĸ 2026-03-08T19:06:24Z
Galderma Group AG (GDERF) Full Year 2025 Earnings Call Highlights: Record Sales and Strategic ...
GuruFocus.com âĸ 2026-03-05T19:00:52ZEuropean Stocks That May Be Trading Below Their Estimated Value In February 2026
Simply Wall St. âĸ 2026-02-17T10:38:11Z
Global Market Highlights 3 Stocks That May Be Trading Below Their Estimated Value
Simply Wall St. âĸ 2026-02-17T09:38:18Z
European Market Highlights 3 Stocks Priced Below Estimated Value
Simply Wall St. âĸ 2026-02-17T05:38:01Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,355,000,000 | $1,232,000,000 | $1,194,000,000 | $1,033,900,000 |
| Cost Of Revenue | $1,355,000,000 | $1,232,000,000 | $1,194,000,000 | $1,033,900,000 |
| Total Revenue | $4,440,000,000 | $4,117,000,000 | $3,823,900,000 | $3,445,000,000 |
| Operating Revenue | $4,440,000,000 | $4,117,000,000 | $3,823,900,000 | $3,445,000,000 |
| Expenses | ||||
| Interest Expense | $356,000,000 | $564,000,000 | $398,400,000 | $352,700,000 |
| Total Expenses | $3,762,000,000 | $3,506,000,000 | $3,417,900,000 | $3,087,800,000 |
| Net Non Operating Interest Income Expense | $-334,000,000 | $-526,000,000 | $-385,400,000 | $-425,700,000 |
| Total Other Finance Cost | $-10,000,000 | $-32,000,000 | $-13,000,000 | $73,000,000 |
| Interest Expense Non Operating | $356,000,000 | $564,000,000 | $398,400,000 | $352,700,000 |
| Operating Expense | $2,407,000,000 | $2,274,000,000 | $2,223,900,000 | $2,053,900,000 |
| Other Operating Expenses | $95,000,000 | $95,000,000 | $83,700,000 | $77,600,000 |
| Selling And Marketing Expense | $1,509,000,000 | $1,425,000,000 | $1,385,000,000 | $1,246,000,000 |
| General And Administrative Expense | $543,000,000 | $467,000,000 | $439,300,000 | $387,700,000 |
| Other Non Operating Income Expenses | - | $-3,100,000 | $-5,100,000 | $-7,700,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $231,000,000 | $-57,000,000 | $-96,900,000 | $-82,300,000 |
| Net Interest Income | $-334,000,000 | $-526,000,000 | $-385,400,000 | $-425,700,000 |
| Interest Income | $12,000,000 | $6,000,000 | $0 | $0 |
| Normalized Income | $245,900,000 | $-18,570,000 | $-30,928,500 | $-17,561,730 |
| Net Income From Continuing And Discontinued Operation | $231,000,000 | $-57,000,000 | $-98,500,000 | $-154,300,000 |
| Total Operating Income As Reported | $645,000,000 | $536,000,000 | $311,100,000 | $264,200,000 |
| Net Income Common Stockholders | $231,000,000 | $-57,000,000 | $-98,500,000 | $-154,300,000 |
| Net Income | $231,000,000 | $-57,000,000 | $-98,500,000 | $-154,300,000 |
| Net Income Including Noncontrolling Interests | $231,000,000 | $-57,000,000 | $-98,500,000 | $-156,200,000 |
| Net Income Continuous Operations | $231,000,000 | $-57,000,000 | $-96,900,000 | $-84,200,000 |
| Pretax Income | $310,000,000 | $11,000,000 | $-51,900,000 | $-79,700,000 |
| Special Income Charges | $-26,000,000 | $-42,000,000 | $-72,100,000 | $-76,100,000 |
| Interest Income Non Operating | $12,000,000 | $6,000,000 | $0 | $0 |
| Operating Income | $678,000,000 | $611,000,000 | $406,000,000 | $357,200,000 |
| Gross Profit | $3,085,000,000 | $2,885,000,000 | $2,629,900,000 | $2,411,100,000 |
| Net Income Discontinuous Operations | - | $0 | $-1,600,000 | $-72,000,000 |
| Per Share | ||||
| Diluted EPS | $0.97 | $-0.24 | $-0.41 | $-0.65 |
| Basic EPS | $0.97 | $-0.24 | $-0.41 | $-0.65 |
| Other | ||||
| Tax Effect Of Unusual Items | $-5,100,000 | $-3,570,000 | $-6,128,500 | $-11,361,730 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $979,000,000 | $893,000,000 | $696,300,000 | $602,200,000 |
| Total Unusual Items | $-20,000,000 | $-42,000,000 | $-72,100,000 | $-76,100,000 |
| Total Unusual Items Excluding Goodwill | $-20,000,000 | $-42,000,000 | $-72,100,000 | $-76,100,000 |
| Reconciled Depreciation | $293,000,000 | $276,000,000 | $277,700,000 | $253,100,000 |
| EBITDA (Bullshit earnings) | $959,000,000 | $851,000,000 | $624,200,000 | $526,100,000 |
| EBIT | $666,000,000 | $575,000,000 | $346,500,000 | $273,000,000 |
| Diluted Average Shares | $237,793,274 | $237,566,428 | $237,566,428 | $237,566,428 |
| Basic Average Shares | $237,515,484 | $237,566,428 | $237,566,428 | $237,566,428 |
| Diluted NI Availto Com Stockholders | $231,000,000 | $-57,000,000 | $-98,500,000 | $-154,300,000 |
| Otherunder Preferred Stock Dividend | $0 | $0 | $0 | $0 |
| Tax Provision | $79,000,000 | $68,000,000 | $45,000,000 | $4,600,000 |
| Other Special Charges | $11,000,000 | $24,000,000 | $23,700,000 | $19,100,000 |
| Write Off | $0 | $1,000,000 | $15,200,000 | $19,000,000 |
| Impairment Of Capital Assets | $0 | $1,000,000 | $15,200,000 | $19,000,000 |
| Restructuring And Mergern Acquisition | $15,000,000 | $17,000,000 | $33,200,000 | $38,000,000 |
| Research And Development | $260,000,000 | $287,000,000 | $315,900,000 | $342,600,000 |
| Selling General And Administration | $2,052,000,000 | $1,892,000,000 | $1,824,300,000 | $1,633,700,000 |
| Minority Interests | - | $0 | $0 | $1,900,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 |
|---|---|---|
| Assets | ||
| Net Tangible Assets | $-2,167,000,000 | $-4,682,000,000 |
| Total Assets | $12,617,000,000 | $12,471,000,000 |
| Total Non Current Assets | $10,774,000,000 | $10,855,000,000 |
| Other Non Current Assets | $25,000,000 | $20,000,000 |
| Non Current Deferred Taxes Assets | $211,000,000 | $235,000,000 |
| Financial Assets | $2,000,000 | $9,000,000 |
| Investmentin Financial Assets | $1,000,000 | $10,000,000 |
| Goodwill And Other Intangible Assets | $9,957,000,000 | $10,051,000,000 |
| Other Intangible Assets | $4,828,000,000 | $4,922,000,000 |
| Current Assets | $1,843,000,000 | $1,616,000,000 |
| Hedging Assets Current | $22,000,000 | $7,000,000 |
| Inventory | $403,000,000 | $420,000,000 |
| Other Receivables | $156,000,000 | $132,000,000 |
| Taxes Receivable | $51,000,000 | $58,000,000 |
| Accounts Receivable | $754,000,000 | $631,000,000 |
| Allowance For Doubtful Accounts Receivable | $-4,000,000 | $-9,000,000 |
| Gross Accounts Receivable | $758,000,000 | $640,000,000 |
| Cash Cash Equivalents And Short Term Investments | $457,000,000 | $368,000,000 |
| Cash And Cash Equivalents | $457,000,000 | $368,000,000 |
| Cash Equivalents | $175,000,000 | $127,000,000 |
| Cash Financial | $282,000,000 | $241,000,000 |
| Assets Held For Sale Current | - | $0 |
| Debt | ||
| Net Debt | $2,186,000,000 | $4,419,000,000 |
| Total Debt | $2,760,000,000 | $4,909,000,000 |
| Long Term Debt And Capital Lease Obligation | $2,724,000,000 | $4,846,000,000 |
| Long Term Debt | $2,637,000,000 | $4,748,000,000 |
| Current Debt And Capital Lease Obligation | $36,000,000 | $63,000,000 |
| Current Debt | $6,000,000 | $39,000,000 |
| Liabilities | ||
| Total Liabilities Net Minority Interest | $4,827,000,000 | $7,102,000,000 |
| Total Non Current Liabilities Net Minority Interest | $3,299,000,000 | $5,531,000,000 |
| Other Non Current Liabilities | $1,000,000 | $200,000 |
| Derivative Product Liabilities | $20,000,000 | $7,000,000 |
| Non Current Deferred Taxes Liabilities | $420,000,000 | $431,000,000 |
| Current Liabilities | $1,528,000,000 | $1,571,000,000 |
| Payables | $737,000,000 | $731,000,000 |
| Other Payable | $62,000,000 | $59,000,000 |
| Total Tax Payable | $104,000,000 | $115,000,000 |
| Accounts Payable | $571,000,000 | $557,000,000 |
| Equity | ||
| Common Stock Equity | $7,790,000,000 | $5,369,000,000 |
| Total Equity Gross Minority Interest | $7,790,000,000 | $5,369,000,000 |
| Stockholders Equity | $7,790,000,000 | $5,369,000,000 |
| Retained Earnings | $5,676,000,000 | $-901,000,000 |
| Other | ||
| Treasury Shares Number | $491,486 | - |
| Ordinary Shares Number | $237,406,149 | $237,566,428 |
| Share Issued | $237,897,635 | $237,566,428 |
| Tangible Book Value | $-2,167,000,000 | $-4,682,000,000 |
| Invested Capital | $10,433,000,000 | $10,156,000,000 |
| Working Capital | $315,000,000 | $45,000,000 |
| Capital Lease Obligations | $117,000,000 | $122,000,000 |
| Total Capitalization | $10,427,000,000 | $10,117,000,000 |
| Treasury Stock | $15,000,000 | $0 |
| Additional Paid In Capital | $2,133,000,000 | $6,253,000,000 |
| Capital Stock | $3,000,000 | $6,000,000 |
| Common Stock | $3,000,000 | $6,000,000 |
| Non Current Pension And Other Postretirement Benefit Plans | $117,000,000 | $221,000,000 |
| Long Term Capital Lease Obligation | $87,000,000 | $98,000,000 |
| Long Term Provisions | $17,000,000 | $16,000,000 |
| Current Capital Lease Obligation | $30,000,000 | $24,000,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $119,000,000 | $127,000,000 |
| Current Provisions | $38,000,000 | $60,000,000 |
| Defined Pension Benefit | $0 | $0 |
| Available For Sale Securities | $1,000,000 | $10,000,000 |
| Goodwill | $5,129,000,000 | $5,129,000,000 |
| Net PPE | $578,000,000 | $530,000,000 |
| Accumulated Depreciation | $-253,000,000 | $-246,000,000 |
| Gross PPE | $831,000,000 | $776,000,000 |
| Construction In Progress | $213,000,000 | $188,000,000 |
| Other Properties | $25,000,000 | $17,000,000 |
| Machinery Furniture Equipment | $266,000,000 | $237,000,000 |
| Buildings And Improvements | $74,000,000 | $86,000,000 |
| Land And Improvements | $253,000,000 | $248,000,000 |
| Properties | $0 | $0 |
| Inventories Adjustments Allowances | $-39,000,000 | $-34,000,000 |
| Finished Goods | $318,000,000 | $335,000,000 |
| Raw Materials | $124,000,000 | $119,000,000 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $213,000,000 | $12,000,000 | $-48,200,000 | $67,700,000 |
| Operating Activities | ||||
| Operating Cash Flow | $488,000,000 | $165,000,000 | $111,300,000 | $195,700,000 |
| Investing Activities | ||||
| Capital Expenditure | $-275,000,000 | $-153,000,000 | $-159,500,000 | $-128,000,000 |
| Investing Cash Flow | $-326,000,000 | $-174,000,000 | $-66,500,000 | $-522,800,000 |
| Net Other Investing Changes | $-1,000,000 | $100,000 | - | $-8,000,000 |
| Capital Expenditure Reported | $-275,000,000 | $-153,000,000 | $-159,500,000 | $-128,000,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-15,000,000 | $0 | - | - |
| Issuance Of Capital Stock | $2,166,000,000 | $1,011,000,000 | $0 | $0 |
| Financing Cash Flow | $-58,000,000 | $142,000,000 | $-79,400,000 | $306,500,000 |
| Net Other Financing Charges | $-1,000,000 | - | $-7,300,000 | $-10,700,000 |
| Net Common Stock Issuance | $2,151,000,000 | $1,011,000,000 | $0 | $0 |
| Common Stock Issuance | $2,166,000,000 | $1,011,000,000 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-5,777,000,000 | $-1,725,000,000 | $-472,100,000 | $-78,800,000 |
| Issuance Of Debt | $3,601,000,000 | $856,000,000 | $400,000,000 | $396,000,000 |
| End Cash Position | $457,000,000 | $368,000,000 | $234,100,000 | $293,600,000 |
| Other Cash Adjustment Outside Changein Cash | $-1,000,000 | $1,000,000 | - | - |
| Beginning Cash Position | $368,000,000 | $234,000,000 | $293,600,000 | $330,700,000 |
| Effect Of Exchange Rate Changes | $-14,000,000 | $0 | $-24,900,000 | $-16,500,000 |
| Changes In Cash | $104,000,000 | $133,000,000 | $-34,600,000 | $-20,600,000 |
| Common Stock Payments | $-15,000,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-2,176,000,000 | $-869,000,000 | $-72,100,000 | $317,200,000 |
| Net Long Term Debt Issuance | $-2,176,000,000 | $-869,000,000 | $-72,100,000 | $317,200,000 |
| Long Term Debt Payments | $-5,777,000,000 | $-1,725,000,000 | $-472,100,000 | $-78,800,000 |
| Long Term Debt Issuance | $3,601,000,000 | $856,000,000 | $400,000,000 | $396,000,000 |
| Net Business Purchase And Sale | $-50,000,000 | $-21,000,000 | $93,000,000 | $-386,800,000 |
| Sale Of Business | $0 | $4,000,000 | $93,000,000 | $0 |
| Purchase Of Business | $-50,000,000 | $-25,000,000 | $0 | $-386,800,000 |
| Taxes Refund Paid | $-90,000,000 | $-87,000,000 | $-73,600,000 | $-48,900,000 |
| Interest Received Cfo | $11,000,000 | $6,000,000 | - | - |
| Interest Paid Cfo | $-286,000,000 | $-532,000,000 | $-339,100,000 | $-305,600,000 |
| Change In Working Capital | $-148,000,000 | $-35,000,000 | $-78,500,000 | $25,600,000 |
| Change In Other Current Assets | $-61,000,000 | $-13,000,000 | $-24,100,000 | $42,700,000 |
| Change In Accrued Expense | $72,000,000 | $-13,000,000 | $-2,900,000 | $-83,200,000 |
| Change In Payable | $64,000,000 | $-66,000,000 | $146,200,000 | $155,200,000 |
| Change In Prepaid Assets | $-3,000,000 | $-21,000,000 | $-3,400,000 | $600,000 |
| Change In Inventory | $-12,000,000 | $31,000,000 | $-127,400,000 | $-52,800,000 |
| Change In Receivables | $-208,000,000 | $47,000,000 | $-66,900,000 | $-36,900,000 |
| Other Non Cash Items | $329,000,000 | $527,000,000 | $362,600,000 | $340,700,000 |
| Stock Based Compensation | $68,000,000 | $0 | - | - |
| Deferred Tax | $79,000,000 | $68,000,000 | $44,800,000 | $-2,000,000 |
| Depreciation And Amortization | $293,000,000 | $276,000,000 | $277,700,000 | $253,100,000 |
| Amortization Cash Flow | $229,000,000 | $221,000,000 | $225,400,000 | $201,700,000 |
| Depreciation | $64,000,000 | $55,000,000 | $52,300,000 | $51,400,000 |
| Gain Loss On Investment Securities | $-6,000,000 | - | - | - |
| Net Foreign Currency Exchange Gain Loss | $7,000,000 | $-2,000,000 | - | - |
| Net Income From Continuing Operations | $231,000,000 | $-57,000,000 | $-98,500,000 | $-156,200,000 |
Fetched: 2026-02-02